Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceGut health

Postbiotics

A legitimate scientific category — inanimate microbes and their components, formally defined by ISAPP in 2021 — that has been adopted by marketing far faster than the human trials have arrived. The shelf-stability advantage over live probiotics is real; the claimed clinical superiority is not yet demonstrated.

What the science says

  • "Postbiotic" has a defined meaning Strong evidence

    The 2021 ISAPP consensus statement defines a postbiotic as a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host. Critically, the definition requires the parent microbe be deliberately inactivated and that a health benefit be demonstrated — most products labeled postbiotic (isolated metabolites, purified filtrates, cell-free supernatants alone) do not meet that bar.

  • Postbiotics work as well as or better than live probiotics Limited evidence

    There is no adequately powered head-to-head evidence supporting superiority. Heat-killed preparations (e.g. tyndallized L. paracasei, heat-treated Akkermansia) have produced positive results in individual small trials on markers like glycemic control and oral hygiene, but n is usually under 100 and independent replication is scarce. The honest position is: promising mechanism, immature evidence base.

  • They are more shelf-stable and safer than live cultures Moderate evidence

    This is the genuine advantage. Inactivated preparations do not lose CFU count over shelf life, tolerate heat and gastric acid, can be added to processed foods, and carry no theoretical risk of translocation or bacteremia — which makes them plausibly preferable for immunocompromised or critically ill people, though outcome trials in those groups are lacking.

  • Postbiotics fix leaky gut or immunity Limited evidence

    Barrier and immune effects are documented largely in cell culture and rodent models. Human trials measuring clinically relevant outcomes such as infection rates, symptom scores or intestinal permeability endpoints are few, small, and inconsistent. Treat category-level immune claims on labels as unsupported.

Dosage & safety

Studied doseThere is no established dose because the category covers wholly different substances. Trials of heat-killed lactobacilli have used the equivalent of 10-100 billion cells/day for 4-12 weeks; short-chain fatty acid postbiotics like butyrate are dosed separately at 300-1,800 mg/day. Labels frequently list "postbiotic blend" with no cell-equivalent count, which makes them impossible to compare to any trial.
SafetyInactivated preparations have a favourable safety profile — no live organism to translocate — and reported adverse events are limited to mild GI upset. That said, most products are unstandardized, ingredient identity is often proprietary, and none are approved to treat any condition. Products containing bacterial lysates or high lipoteichoic acid content have not been well studied for long-term daily use; anyone immunosuppressed or pregnant should check with a clinician rather than assume safety from the "inanimate" label.

Scientific references

Where to buy

Bio-Strath, Fermented Herbal Yeast Postbiotic, 100 Tablets

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Gut health